Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Kodiak Sciences Inc KOD

Healthcare Biotechnology
Kodiak Sciences Inc. is a biopharmaceutical company. The Company has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) Platform, for retinal medicines. Its ABC Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies. Its lead investigational medicine, tarcocimab tedromer, is a novel anti-vascular endothelial growth factor... see more

Recent & Breaking News (NDAQ:KOD)

Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

PR Newswire March 27, 2025

Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy

PR Newswire March 10, 2025

Kodiak Sciences to Present at Glaucoma 360 New Horizons Forum 2025

PR Newswire February 4, 2025

Kodiak Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference

PR Newswire January 7, 2025

Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2024 Financial Results

PR Newswire November 14, 2024

Kodiak Sciences to Participate in Upcoming Investor Conferences

PR Newswire November 11, 2024

Kodiak Sciences to Present at Innovate Retina 2024

PR Newswire October 14, 2024

Kodiak Sciences to Host Investor R&D Day Today at 10:30am Eastern Time

PR Newswire September 23, 2024

Kodiak Sciences to Host Investor R&D Day on September 23, 2024 in New York City

PR Newswire September 17, 2024

Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2024 Financial Results

PR Newswire August 14, 2024

Kodiak Sciences to Present at Upcoming Investor and Clinical Conferences

PR Newswire May 29, 2024

Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results

PR Newswire May 15, 2024

Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy

PR Newswire May 13, 2024

Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform

PR Newswire May 2, 2024

Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

PR Newswire March 28, 2024

Kodiak Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results and Host Business Updates Webcast on March 28, 2024

PR Newswire March 26, 2024

Kodiak Sciences Announces Upcoming Presentation of First Time Results of KSI-501ABC Phase 1 Study at the Angiogenesis, Exudation, and Degeneration 2024 Virtual Meeting

PR Newswire January 30, 2024

Kodiak Sciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

PR Newswire January 4, 2024

Kodiak Sciences to Present at the 6th Annual Evercore ISI HealthCONx Conference

PR Newswire November 21, 2023

Kodiak Sciences Announces Third Quarter 2023 Financial Results and Recent Business Highlights

PR Newswire November 14, 2023